| Teva Pharma AG - Pomalidomid-Teva Mepha 3 mg, Hartkapseln | | 69497 | | 03 | | Pomalidomid-Teva Mepha 3 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 11.10.2024 | | |
| | Composition | | pomalidomidum 3 mg, isomaltum 75.3 mg, amylum pregelificatum, natrii stearylis fumaras, Kapselhülle: gelatina, aqua purificata, E 133, E 171, Drucktinte: lacca, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.05 mg. | | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
|---|
| Pomalidomidum | 3 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Amylum Pregelificatum | | | | Aqua Purificata | | | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Isomaltum | 75.3 mg | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Natrii Stearylis Fumaras | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 14 | PR | PR | A | | No | | 006 | 21 | PR | PR | A | | No |
|
|
